Table 3.
The study of complement activation in mice models during coronavirus infection
| Genotype | Collective evidence of complement activation | References |
|---|---|---|
| WT | Complement is activated after SARS-CoV MA15 (the mouse-adapted SARS-CoV) infection as demonstrated by elevated C3 activation products (C3 fragments C3a, C3b, iC3b, C3dg, and C3c) | Gralinski et al. [32] |
| C3−/− | C3−/− mice showed a partial reduction of respiratory dysfunction, pathology, immune cell infiltration, and cytokine responses in the lung, compared with WT mice | Gralinski et al. [32] |
| B−/− | Factor B−/− mice had less weight loss than WT mice | Gralinski et al. [32] |
| C4−/− | C4−/− mice had less weight loss than WT mice | Gralinski et al. [32] |